News Chart Exalenz Bioscience Ltd

Equities

EXEN

IL0011048688

Delayed TEL AVIV STOCK EXCHANGE Other stock markets			5-day change	1st Jan Change
- ^ILa	-.--%		+1.39%	+107.88%

2020	Meridian Bioscience, Inc. completed the acquisition of Exalenz Bioscience Ltd from Mori Arkin and others.	CI
2020	Meridian Bioscience, Inc. agreed to acquire Exalenz Bioscience Ltd from Mori Arkin and others for approximately ILS 170 million.	CI

43eeba29556241.DbzH4-NlXba51NvGgnRGs5m6DhrQcJX7-K6YLGZKuag.VNSFu9IcBZvQpo725iAfwezcYlmfG-e3ucrTSTcdgN1u9YnStDw7wMmT6w~1b8ca3fbf4c69871d6123af795fac4bf